Long-term immunogenicity of a live attenuated herpes zoster vaccine in patients with systemic lupus erythematosus
Authors:
Abstract
No abstract availableKeywords
Funding Information
- Hong Kong Society of Rheumatology
This publication has 28 references indexed in Scilit:
- Immunogenicity, reactogenicity, and safety of two-dose adjuvanted herpes zoster subunit vaccine in patients with systemic lupus erythematosus in South Korea: a single-centre, randomised, double-blind, placebo-controlled trialThe Lancet Rheumatology, 2024
- Hesitancy for SARS-CoV-2 vaccines and post-vaccination flares in patients with systemic lupus erythematosusVaccine, 2022
- Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysisThe Lancet Infectious Diseases, 2019
- Long-term effectiveness of zoster vaccine live for postherpetic neuralgia preventionVaccine, 2019
- Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell TransplantationJAMA, 2019
- Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in patients with solid tumors, vaccinated before or during chemotherapy: A randomized trialCancer, 2019
- Association Between Vaccination for Herpes Zoster and Risk of Herpes Zoster Infection Among Older Patients With Selected Immune-Mediated DiseasesJAMA, 2012
- Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosusArthritis & Rheumatism, 2012
- A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older AdultsNew England Journal of Medicine, 2005
- Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1997